The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.
Arginine dependence of tumor cells: targeting a chink in cancer’s armor
Open accessAbstract
Arginine, one among the 20 most common natural amino acids, has a pivotal role in cellular physiology as it is being involved in numerous cellular metabolic and signaling pathways. Dependence on arginine is diverse for both tumor and normal cells. Because of decreased expression of argininosuccinate synthetase and/or ornithine transcarbamoylase, several types of tumor are auxotrophic for arginine. Deprivation of arginine exploits a significant vulnerability of these tumor cells and leads to their rapid demise. Hence, enzyme-mediated arginine depletion is a potential strategy for the selective destruction of tumor cells. Arginase, arginine deiminase and arginine decarboxylase are potential enzymes that may be used for arginine deprivation therapy. These arginine catabolizing enzymes not only reduce tumor growth but also make them susceptible to concomitantly administered anti-cancer therapeutics. Most of these enzymes are currently under clinical investigations and if successful will potentially be advanced as anti-cancer modalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Arginine metabolism: nitric oxide and beyond
WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811
The mechanism of eukaryotic translation initiation and principles of its regulation
Jackson, R. J., Hellen, C. U. T., & Pestova, T. V. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2838 · Cited by 2,759
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605
Self-citationTargeting cancer metabolism: a therapeutic window opens
Vander Heiden, M. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,411
Autophagy as a cell death and tumor suppressor mechanism
Gozuacik, D., & Kimchi, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207521 · Cited by 1,384
Hara, K., Yonezawa, K., Weng, Q.-P., Kozlowski, M. T., Belham, C., & Avruch, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14484 · Cited by 1,367
Arginine metabolism and nutrition in growth, health and disease
Wu, G., Bazer, F. W., Davis, T. A., Kim, S. W., Li, P., Marc Rhoads, J., Carey Satterfield, M., Smith, S. B., Spencer, T. E., & Yin, Y. (2009) · Amino Acids · doi:10.1007/s00726-008-0210-y · Cited by 1,362
The role of nitric oxide in tumour progression
Fukumura, D., Kashiwagi, S., & Jain, R. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1910 · Cited by 1,259
Self-citationPolyamines and cancer: old molecules, new understanding
Gerner, E. W., & Meyskens, F. L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1454 · Cited by 1,159
Fukumura, D., Gohongi, T., Kadambi, A., Izumi, Y., Ang, J., Yun, C.-O., Buerk, D. G., Huang, P. L., & Jain, R. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041359198 · Cited by 1,020
Self-citationCancer Cell Metabolism: One Hallmark, Many Faces
Cantor, J. R., & Sabatini, D. M. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0345 · Cited by 947
Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1
Wang, S., Tsun, Z.-Y., Wolfson, R. L., Shen, K., Wyant, G. A., Plovanich, M. E., Yuan, E. D., Jones, T. D., Chantranupong, L., Comb, W., et al. (2015) · Science · doi:10.1126/science.1257132 · Cited by 824
Functional amino acids in nutrition and health
Wu, G. (2013) · Amino Acids · doi:10.1007/s00726-013-1500-6 · Cited by 778
Jiang, P., & Mizushima, N. (2014) · Cell Research · doi:10.1038/cr.2013.161 · Cited by 775
Another way to die: autophagic programmed cell death
Tsujimoto, Y., & Shimizu, S. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401777 · Cited by 754
Agmatine: an Endogenous Clonidine-Displacing Substance in the Brain
Li, G., Regunathan, S., Barrow, C. J., Eshraghi, J., Cooper, R., & Reis, D. J. (1994) · Science · doi:10.1126/science.7906055 · Cited by 738
Chen, Y., McMillan-Ward, E., Kong, J., Israels, S. J., & Gibson, S. B. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402233 · Cited by 688
SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1
Rebsamen, M., Pochini, L., Stasyk, T., de Araújo, M. E. G., Galluccio, M., Kandasamy, R. K., Snijder, B., Fauster, A., Rudashevskaya, E. L., Bruckner, M., et al. (2015) · Nature · doi:10.1038/nature14107 · Cited by 673
Arginine Metabolism: Boundaries of Our Knowledge
Morris, S. M. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.6.1602s · Cited by 637
Endothelial Cell Metabolism in Normal and Diseased Vasculature
Eelen, G., de Zeeuw, P., Simons, M., & Carmeliet, P. (2015) · Circulation Research · doi:10.1161/circresaha.116.302855 · Cited by 627
Comparative properties of arginases
Jenkinson, C. P., Grody, W. W., & Cederbaum, S. D. (1996) · Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology · doi:10.1016/0305-0491(95)02138-8 · Cited by 606
Polyamines: metabolism and implications in human diseases
MOINARD, C., CYNOBER, L., & DEBANDT, J. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2004.11.001 · Cited by 456
Metabolic flux and the regulation of mammalian cell growth
Locasale, J. W., & Cantley, L. C. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.07.014 · Cited by 449
Amino acids and mTORC1: from lysosomes to disease
Efeyan, A., Zoncu, R., & Sabatini, D. M. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.05.007 · Cited by 436
Wang, Y., Nartiss, Y., Steipe, B., McQuibban, G. A., & Kim, P. K. (2012) · Autophagy · doi:10.4161/auto.21211 · Cited by 426
Dietary requirements of “nutritionally non-essential amino acids” by animals and humans
Wu, G., Wu, Z., Dai, Z., Yang, Y., Wang, W., Liu, C., Wang, B., Wang, J., & Yin, Y. (2013) · Amino Acids · doi:10.1007/s00726-012-1444-2 · Cited by 392
Popovic, P. J., Zeh, H. J., & Ochoa, J. B. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.6.1681s · Cited by 391
Li, H., Meininger, C. J., Hawker, J. R., Haynes, T. E., Kepka-Lenhart, D., Mistry, S. K., Morris, S. M., & Wu, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.1.e75 · Cited by 389
Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1
Djavaheri-Mergny, M., Maiuri, M. C., & Kroemer, G. (2010) · Oncogene · doi:10.1038/onc.2009.519 · Cited by 388
Autophagy: A Critical Regulator of Cellular Metabolism and Homeostasis
Ryter, S. W., Cloonan, S. M., & Choi, A. M. K. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0140-8 · Cited by 385
Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis
Rabinovich, S., Adler, L., Yizhak, K., Sarver, A., Silberman, A., Agron, S., Stettner, N., Sun, Q., Brandis, A., Helbling, D., et al. (2015) · Nature · doi:10.1038/nature15529 · Cited by 382
Cell death by autophagy: facts and apparent artefacts
Denton, D., Nicolson, S., & Kumar, S. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.146 · Cited by 381
The role of cell signalling in the crosstalk between autophagy and apoptosis
Booth, L. A., Tavallai, S., Hamed, H. A., Cruickshanks, N., & Dent, P. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.028 · Cited by 341
Various modes of cell death induced by DNA damage
Surova, O., & Zhivotovsky, B. (2013) · Oncogene · doi:10.1038/onc.2012.556 · Cited by 334
Autophagic cell death: Loch Ness monster or endangered species?
Shen, H.-M., & Codogno, P. (2011) · Autophagy · doi:10.4161/auto.7.5.14226 · Cited by 327
Pegaspargase: a review of clinical studies
Graham, M. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00110-8 · Cited by 322
Raber, P., Ochoa, A. C., & Rodríguez, P. C. (2012) · Immunological Investigations · doi:10.3109/08820139.2012.680634 · Cited by 322
Kim, R. H., Coates, J. M., Bowles, T. L., McNerney, G. P., Sutcliffe, J., Jung, J. U., Gandour-Edwards, R., Chuang, F. Y. S., Bold, R. J., & Kung, H.-J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3157 · Cited by 317
Ensor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2002) · PubMed · Cited by 315
Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy
Fulda, S., & Kögel, D. (2015) · Oncogene · doi:10.1038/onc.2014.458 · Cited by 307
Activated macrophages kill tumour cells by releasing arginase
CURRIE, G. A. (1978) · Nature · doi:10.1038/273758a0 · Cited by 301
Leucine and mTORC1: a complex relationship
Dodd, K. M., & Tee, A. R. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00525.2011 · Cited by 293
Mitochondrial control of caspase-dependent and -independent cell death
Pradelli, L. A., Bénéteau, M., & Ricci, J.-E. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0285-y · Cited by 285
Mandal, S., Mandal, A., Johansson, H. E., Orjalo, A. V., & Park, M. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219002110 · Cited by 285
Cheng, P. N.-M., Lam, T.-L., Lam, W.-M., Tsui, S.-M., Cheng, A. W.-M., Lo, W.-H., & Leung, Y.-C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1945 · Cited by 277
Mitochondrial regulation of cell death: Processing of apoptosis-inducing factor (AIF)
Norberg, E., Orrenius, S., & Zhivotovsky, B. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.163 · Cited by 268
VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2
Zhao, D., Pan, C., Sun, J., Gilbert, C., Drews-Elger, K., Azzam, D. J., Picon-Ruiz, M., Kim, M., Ullmer, W., El-Ashry, D., et al. (2015) · Oncogene · doi:10.1038/onc.2014.257 · Cited by 267
Tumor angiogenesis and accessibility: Role of vascular endothelial growth factor
JAIN, R. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70063-8 · Cited by 256
Regulation of Enzymes of Urea and Arginine Synthesis
Morris, S. M. (1992) · Annual Review of Nutrition · doi:10.1146/annurev.nu.12.070192.000501 · Cited by 252
Izzo, F., Marra, P., Beneduce, G., Castello, G., Vallone, P., De Rosa, V., Cremona, F., Ensor, C. M., Holtsberg, F. W., Bomalaski, J. S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.120 · Cited by 250
Reduced methylation of PFKFB3 in cancer cells shunts glucose towards the pentose phosphate pathway
Yamamoto, T., Takano, N., Ishiwata, K., Ohmura, M., Nagahata, Y., Matsuura, T., Kamata, A., Sakamoto, K., Nakanishi, T., Kubo, A., et al. (2014) · Nature Communications · doi:10.1038/ncomms4480 · Cited by 250
The autophagic paradox in cancer therapy
Wu, W. K. K., Coffelt, S. B., Cho, C. H., Wang, X. J., Lee, C. W., Chan, F. K. L., Yu, J., & Sung, J. J. Y. (2012) · Oncogene · doi:10.1038/onc.2011.295 · Cited by 248
Glutathione synthesis and its role in redox signaling
Zhang, H., & Forman, H. J. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.03.017 · Cited by 245
Tumor angiogenesis and accessibility: Role of vascular endothelial growth factor
Jain, R. K. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.37265 · Cited by 242
Ascierto, P. A., Scala, S., Castello, G., Daponte, A., Simeone, E., Ottaiano, A., Beneduce, G., De Rosa, V., Izzo, F., Melucci, M. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0933 · Cited by 238
Gotoh, T., Sonoki, T., Nagasaki, A., Terada, K., Takiguchi, M., & Mori, M. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)01015-0 · Cited by 236
Mitochondrial ROS generation for regulation of autophagic pathways in cancer
Li, Z.-Y., Yang, Y., Ming, M., & Liu, B. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.046 · Cited by 235
Tsai, W.-B., Aiba, I., Long, Y., Lin, H.-K., Feun, L., Savaraj, N., & Kuo, M. T. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3605 · Cited by 233
Arginine Deprivation as a Targeted Therapy for Cancer
Feun, L., You, M., Wu, C., Kuo, M., Wangpaichitr, M., Spector, S., & Savaraj, N. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784246199 · Cited by 233
Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges
Phillips, M. M., Sheaff, M. T., & Szlosarek, P. W. (2013) · Cancer Research and Treatment · doi:10.4143/crt.2013.45.4.251 · Cited by 229
Apoptosis: why and how does it occur in biology?
Ulukaya, E., Acilan, C., & Yilmaz, Y. (2011) · Cell Biochemistry and Function · doi:10.1002/cbf.1774 · Cited by 228
l-Arginine stimulates proliferation and prevents endotoxin-induced death of intestinal cells
Tan, B., Yin, Y., Kong, X., Li, P., Li, X., Gao, H., Li, X., Huang, R., & Wu, G. (2010) · Amino Acids · doi:10.1007/s00726-009-0334-8 · Cited by 225
Zhu, C., Wang, X., Deinum, J., Huang, Z., Gao, J., Modjtahedi, N., Neagu, M. R., Nilsson, M., Eriksson, P. S., Hagberg, H., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070193 · Cited by 223
Satriano, J. (2004) · Amino Acids · doi:10.1007/s00726-004-0078-4 · Cited by 214
Changou, C. A., Chen, Y.-R., Xing, L., Yen, Y., Chuang, F. Y. S., Cheng, R. H., Bold, R. J., Ann, D. K., & Kung, H.-J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404171111 · Cited by 189
Kashiwagi, S., Izumi, Y., Gohongi, T., Demou, Z. N., Xu, L., Huang, P. L., Buerk, D. G., Munn, L. L., Jain, R. K., & Fukumura, D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24015 · Cited by 188
Self-citationGlazer, E. S., Piccirillo, M., Albino, V., Di Giacomo, R., Palaia, R., Mastro, A. A., Beneduce, G., Castello, G., De Rosa, V., Petrillo, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7765 · Cited by 187
Lind, D. S. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.10.2837s · Cited by 184
Perivascular nitric oxide gradients normalize tumor vasculature
Kashiwagi, S., Tsukada, K., Xu, L., Miyazaki, J., Kozin, S. V., Tyrrell, J. A., Sessa, W. C., Gerweck, L. E., Jain, R. K., & Fukumura, D. (2008) · Nature Medicine · doi:10.1038/nm1730 · Cited by 183
Self-citationSzlosarek, P. W., Klabatsa, A., Pallaska, A., Sheaff, M., Smith, P., Crook, T., Grimshaw, M. J., Steele, J. P., Rudd, R. M., Balkwill, F. R., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1101 · Cited by 181
Scott, L., Lamb, J., Smith, S., & Wheatley, D. N. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1353 · Cited by 178
Role of arginine metabolism in immunity and immunopathology
Peranzoni, E., Marigo, I., Dolcetti, L., Ugel, S., Sonda, N., Taschin, E., Mantelli, B., Bronte, V., & Zanovello, P. (2008) · Immunobiology · doi:10.1016/j.imbio.2007.09.008 · Cited by 178
Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates
Lee, M. Y., Luciano, A. K., Ackah, E., Rodriguez-Vita, J., Bancroft, T. A., Eichmann, A., Simons, M., Kyriakides, T. R., Morales-Ruiz, M., & Sessa, W. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408472111 · Cited by 176
Mitochondrial effectors in caspase‐independent cell death
Lorenzo, H. K., & Susin, S. A. (2004) · FEBS Letters · doi:10.1016/s0014-5793(03)01464-9 · Cited by 173
Autophagic and apoptotic response to stress signals in mammalian cells
Ferraro, E., & Cecconi, F. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.02.006 · Cited by 170
Syed, N., Langer, J., Janczar, K., Singh, P., Lo Nigro, C., Lattanzio, L., Coley, H. M., Hatzimichael, E., Bomalaski, J., Szlosarek, P., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2012.197 · Cited by 168
Chamorro-Jorganes, A., Lee, M. Y., Araldi, E., Landskroner-Eiger, S., Fernández-Fuertes, M., Sahraei, M., Quiles del Rey, M., van Solingen, C., Yu, J., Fernández-Hernando, C., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.307408 · Cited by 163
The multifaceted activity of VEGF in angiogenesis – Implications for therapy responses
Moens, S., Goveia, J., Stapor, P. C., Cantelmo, A. R., & Carmeliet, P. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.009 · Cited by 159
Yang, T.-S., Lu, S.-N., Chao, Y., Sheen, I.-S., Lin, C.-C., Wang, T.-E., Chen, S.-C., Wang, J.-H., Liao, L.-Y., Thomson, J. A., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605856 · Cited by 159
The evolution of the TOR pathway and its role in cancer
Beauchamp, E. M., & Platanias, L. C. (2012) · Oncogene · doi:10.1038/onc.2012.567 · Cited by 158
Targeting arginine metabolism pathway to treat arginine-dependent cancers
Qiu, F., Huang, J., & Sui, M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.020 · Cited by 158
Sikalidis, A. K. (2014) · Pathology & Oncology Research · doi:10.1007/s12253-014-9860-0 · Cited by 156
Holtsberg, F. W., Ensor, M., Steiner, M. R., Bomalaski, J. S., & Clark, M. A. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00042-1 · Cited by 155
Huang, H.-Y., Wu, W.-R., Wang, Y.-H., Wang, J., Fang, F.-M., Tsai, J.-W., Li, S.-H., Hung, H.-C., Yu, S.-C., Lan, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2641 · Cited by 155
Bowles, T. L., Kim, R., Galante, J., Parsons, C. M., Virudachalam, S., Kung, H., & Bold, R. J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23723 · Cited by 153
Allen, M. D., Luong, P., Hudson, C. D., Leyton, J., Delage, B., Ghazaly, E. A., Cutts, R. J., Yuan, M., Syed, N., Nigro, C. L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1702 · Cited by 153
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma
Ott, P. A., Carvajal, R. D., Pandit-Taskar, N., Jungbluth, A. A., Hoffman, E. W., Wu, B.-W., Bomalaski, J. S., Venhaus, R., Pan, L., Old, L. J., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-012-9862-2 · Cited by 146
The Transcription Factor Network Associated With the Amino Acid Response in Mammalian Cells
Kilberg, M. S., Balasubramanian, M. N., Fu, L., & Shan, J. (2012) · Advances in Nutrition · doi:10.3945/an.112.001891 · Cited by 146
Tsai, W.-B., Aiba, I., Lee, S.-Y., Feun, L. G., Savaraj, N., & Kuo, M. T. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0794 · Cited by 144
Delage, B., Luong, P., Maharaj, L., Ó’Riain, C., Syed, N., Crook, T., Hatzimichael, E. C., Papoudou‐Bai, A., Mitchell, T. J., Whittaker, S. J., et al. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.83 · Cited by 142
Gong, H., Zölzer, F., Recklinghausen, G. V., Havers, W., & Schweigerer, L. (2000) · Leukemia · doi:10.1038/sj.leu.2401763 · Cited by 138
Satriano, J. A., Matsufuji, S., Murakami, Y., Lortie, M. J., Schwartz, D., Kelly, C., Hayashi, S., & Blantz, R. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15313 · Cited by 137
Icard, P., & Lincet, H. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.07.001 · Cited by 135
Nicholson, L. J., Smith, P. R., Hiller, L., Szlosarek, P. W., Kimberley, C., Sehouli, J., Koensgen, D., Mustea, A., Schmid, P., & Crook, T. (2009) · International Journal of Cancer · doi:10.1002/ijc.24546 · Cited by 133
Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
Jurasz, P., Sawicki, G., Duszyk, M., Sawicka, J. M., Miranda, C., Mayers, I., & Radomski, M. W. (2001) · PubMed · Cited by 129
Metabolic reprogramming of the tumor
Ferreira, L. M. R., Hébrant, A., & Dumont, J. E. (2012) · Oncogene · doi:10.1038/onc.2011.576 · Cited by 129
Arginine deiminase, a potential anti-tumor drug
Ni, Y., Schwaneberg, U., & Sun, Z. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.038 · Cited by 127
Stone, E. M., Glazer, E. S., Chantranupong, L., Cherukuri, P., Breece, R. M., Tierney, D. L., Curley, S. A., Iverson, B. L., & Georgiou, G. (2010) · ACS Chemical Biology · doi:10.1021/cb900267j · Cited by 122
Autophagy in tumour cell death
Macintosh, R. L., & Ryan, K. M. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.05.006 · Cited by 122
Kobayashi, E., Masuda, M., Nakayama, R. T., Ichikawa, H., Satow, R., Shitashige, M., Honda, K., Yamaguchi, U., Shoji, A., Tochigi, N., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0774 · Cited by 122
Long, Y., Tsai, W.-B., Wangpaichitr, M., Tsukamoto, T., Savaraj, N., Feun, L. G., & Kuo, M. T. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0302 · Cited by 121
The role of autophagy in liver cancer: Molecular mechanisms and potential therapeutic targets
Cui, J., Gong, Z., & Shen, H. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.02.003 · Cited by 120
A novel superfamily of enzymes that catalyze the modification of guanidino groups
Shirai, H., Blundell, T. L., & Mizuguchi, K. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01906-5 · Cited by 120
Arginine: Clinical potential of a semi-essential amino acid..
Appleton, J. (2002) · PubMed · Cited by 119
Kelly, M. P., Jungbluth, A. A., Wu, B.-W., Bomalaski, J. S., Old, L. J., & Ritter, G. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.524 · Cited by 118
Pegylated arginine deiminase: a novel anticancer enzyme agent
Feun, L. G., & Savaraj, N. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.7.815 · Cited by 118
Miyazaki, K., Takaku, H., Umeda, M., Fujita, T., Huang, W. D., Kimura, T., Yamashita, J., & Horio, T. (1990) · PubMed · Cited by 115
Feun, L. G., Marini, A., Walker, G., Elgart, G., Moffat, F., Rodgers, S. E., Wu, C. J., You, M., Wangpaichitr, M., Kuo, M. T., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.106 · Cited by 113
Arginine Deprivation, Autophagy, Apoptosis (AAA) for the Treatment of Melanoma
Savaraj, N., You, M., Wu, C., Wangpaichitr, M., Kuo, M. T., & Feun, L. G. (2010) · Current Molecular Medicine · doi:10.2174/156652410791316995 · Cited by 112
Metabolic control of the cell cycle
Kalucka, J. M., Missiaen, R., Γεωργιάδου, Μ., Schoors, S., Lange, C. M., Bock, K. D., Dewerchin, M. A., & Carmeliet, P. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1090068 · Cited by 109
Pegylated arginase I: a potential therapeutic approach in T-ALL
Hernandez, C. P., Morrow, K. D., Lopez-Barcons, L. A., Zabaleta, J., Sierra, R. A., Velasco, C., COLE, J. T., & Rodríguez, P. C. (2010) · Blood · doi:10.1182/blood-2009-12-258822 · Cited by 109
Yau, T. C. C., Cheng, P. N.-M., Chan, P., Chan, W., Chen, L., Yuen, J. H. F., Pang, R. W. C., Fan, S. T., & Poon, R. T. P. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9807-9 · Cited by 109
Characterization of Arginine Decarboxylase in Rat Brain and Liver
Regunathan, S., & Reis, D. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742201.x · Cited by 108
Expression of human arginine decarboxylase, the biosynthetic enzyme for agmatine
Zhu, M. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2003.11.006 · Cited by 108
Palii, S. S., Kays, C. E., Deval, C., Bruhat, A., Fafournoux, P., & Kilberg, M. S. (2008) · Amino Acids · doi:10.1007/s00726-008-0199-2 · Cited by 106
Cao, Z., Shang, B., Zhang, G., Miele, L., Sarkar, F. H., Wang, Z. P., & Zhou, Q. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.08.001 · Cited by 105
Philip, R., Campbell, E., & Wheatley, D. N. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600681 · Cited by 103
Agmatine (decarboxylated l-arginine): Physiological role and therapeutic potential
Molderings, G. J., & Haenisch, B. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.12.005 · Cited by 101
Lam, A. T., Wong, G., Chow, H., Chong, H.-C., Chow, T. L., Kwok, S.-Y., Cheng, P. N.-M., Wheatley, D. N., Lo, W., & Leung, Y. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00798.x · Cited by 99
Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth
Is, P., Kang, S.-W., Shin, Y.-J., Chae, K.-Y., Park, M.-O., Kim, M. Y., Wheatley, D. N., & Min, B.-H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601181 · Cited by 97
Angiogenesis revisited – role and therapeutic potential of targeting endothelial metabolism
Stapor, P. C., Wang, X., Goveia, J., Moens, S., & Carmeliet, P. (2014) · Journal of Cell Science · doi:10.1242/jcs.153908 · Cited by 97
Ambra1 at the crossroad between autophagy and cell death
Fimia, G. M., Corazzari, M., Antonioli, M., & Piacentini, M. (2012) · Oncogene · doi:10.1038/onc.2012.455 · Cited by 96
Metabolic pathway compartmentalization: an underappreciated opportunity?
Zecchin, A., Stapor, P. C., Goveia, J., & Carmeliet, P. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.11.022 · Cited by 95
García‐Navas, R., Munder, M., & Mollinedo, F. (2012) · Autophagy · doi:10.4161/auto.21315 · Cited by 93
Translation factors and ribosomal proteins control tumor onset and progression: how?
Loreni, F., Mancino, M., & Biffo, S. (2013) · Oncogene · doi:10.1038/onc.2013.153 · Cited by 92
Tomlinson, B. K., Thomson, J. A., Bomalaski, J. S., Diaz, M., Akande, T., Mahaffey, N., Li, T., Dutia, M. P., Kelly, K. L., Gong, I.-Y., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2610 · Cited by 90
Carreau, A., Kieda, C., & Grillon, C. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.08.011 · Cited by 88
Lam, T. L., Wong, G., Chong, H.-C., Cheng, P. N.-M., Choi, S. C., Chow, T. L., Kwok, S.-Y., Poon, R. T. P., Wheatley, D. N., Lo, W., et al. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.11.031 · Cited by 87
Deprivation of arginine by recombinant human arginase in prostate cancer cells
Hsueh, E. C., Knebel, S. M., Lo, W., Leung, Y., Cheng, P. N.-M., & Hsueh, C.-T. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-17 · Cited by 84
Arginine deprivation in cancer therapy
Feun, L. G., Kuo, M. T., & Savaraj, N. (2014) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000122 · Cited by 84
The autophagy conundrum in cancer: influence of tumorigenic metabolic reprogramming
Eng, C. H., & Abraham, R. T. (2011) · Oncogene · doi:10.1038/onc.2011.220 · Cited by 83
Sugimura, K., Ohno, T., Kusuyama, T., & Azuma, I. (1992) · Melanoma Research · doi:10.1097/00008390-199209000-00007 · Cited by 83
Elms, S. C., Chen, F., Wang, Y., Qian, J., Askari, B., Yu, Y., Pandey, D., Iddings, J. A., Caldwell, R. B., & Fulton, D. J. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00755.2012 · Cited by 83
Arginine Deiminase Inhibits Cell Proliferation by Arresting Cell Cycle and Inducing Apoptosis
Gong, H., Zölzer, F., Recklinghausen, G. V., Rössler, J. K., Breit, S., Havers, W., Fotsis, T., & Schweigerer, L. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1004 · Cited by 76
Tsui, S. M., Lam, W.-M., Lam, T. L., Chong, H.-C., So, P., Kwok, S.-Y., Arnold, S., Cheng, P. N.-M., Wheatley, D. N., Lo, W., et al. (2009) · Cancer Cell International · doi:10.1186/1475-2867-9-9 · Cited by 76
Wheatley, D. N. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200410000-00002 · Cited by 74
You, M., Savaraj, N., Kuo, M. T., Wangpaichitr, M., Varona-Santos, J., Wu, C., Nguyen, D. M., & Feun, L. G. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1518-1 · Cited by 73
Szlosarek, P. W., Luong, P., Phillips, M. M., Baccarini, M., Ellis, S. M., Szyszko, T. A., Sheaff, M. T., & Avril, N. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.1784 · Cited by 73
Recombinant arginine deiminase as a potential anti-angiogenic agent
Beloussow, K., Wang, L., Wu, J., Ann, D. K., & Shen, W. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00793-5 · Cited by 71
Role of Nitric Oxide in Tumor Angiogenesis
Morbidelli, L., Donnini, S., & Ziche, M. (2004) · Cancer treatment and research · doi:10.1007/978-1-4419-8871-3_11 · Cited by 70
Nitric Oxide and Its Gatekeeper Thrombospondin-1 in Tumor Angiogenesis
Roberts, D. D., Isenberg, J. S., Ridnour, L. A., & Wink, D. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1758 · Cited by 69
Decreased Expression of Cystathionine β-Synthase Promotes Glioma Tumorigenesis
Takano, N., Sarfraz, Y., Gilkes, D. M., Chaturvedi, P., Xiang, L., Suematsu, M., Zagzag, D., & Semenza, G. L. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0184 · Cited by 68
McAlpine, J. A., Lu, H.-T., Wu, K. C., Knowles, S. K., & Thomson, J. A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-621 · Cited by 67
Glazer, E. S., Stone, E. M., Zhu, C., Massey, K. L., Hamir, A. N., & Curley, S. A. (2011) · Translational Oncology · doi:10.1593/tlo.10265 · Cited by 67
Wang, Z., Shi, X., Li, Y., Fan, J., Zeng, X. L., Xian, Z., Wang, Z., Sun, Y., Wang, S., Song, P., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.503 · Cited by 67
Wheatley, D. N., Scott, L., Lamb, J., & Smith, S. H. (2000) · Cellular Physiology and Biochemistry · doi:10.1159/000016333 · Cited by 64
Khoury, O., Ghazale, N., Stone, E. M., El‐Sibai, M., Frankel, A. E., & Abi‐Habib, R. J. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1698-5 · Cited by 64
Cell proliferation, potassium channels, polyamines and their interactions: a mini review
Weiger, T. M., & Hermann, A. (2013) · Amino Acids · doi:10.1007/s00726-013-1536-7 · Cited by 60
AIF, reactive oxygen species, and neurodegeneration: A “complex” problem
Polster, B. M. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.002 · Cited by 59
Dillon, B. J., Holtsberg, F. W., Ensor, M., Bomalaski, J. S., & Clark, M. A. (2002) · PubMed · Cited by 58
Shen, L., Beloussow, K., & Shen, W. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.01.007 · Cited by 58
Tanios, R. F., Bekdash, A., Kassab, E., Stone, E. M., Georgiou, G., Frankel, A. E., & Abi‐Habib, R. J. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.08.007 · Cited by 56
ADI, autophagy and apoptosis: Metabolic stress as a therapeutic option for prostate cancer
Kim, R. H., Bold, R. J., & Kung, H.-J. (2009) · Autophagy · doi:10.4161/auto.5.4.8252 · Cited by 56
The Effect of Arginase on the Retardation of Tumour Growth
Bach, S. J., & Swaine, D. (1965) · British Journal of Cancer · doi:10.1038/bjc.1965.45 · Cited by 55
Agmatine modulates the in vivo biosynthesis and interconversion of polyamines and cell proliferation
Dudkowska, M., Lai, J., Gardini, G., et al. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00476-2 · Cited by 54
Wheatley, D. N., & Campbell, E. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601134 · Cited by 53
Qie, S., Liang, D., Yin, C., Gu, W., Meng, M., Wang, C., & Sang, N. (2012) · Cell Cycle · doi:10.4161/cc.21944 · Cited by 52
Fu, Y., Yu, Z., Li, Y., Ge, X., Sanchez, P. J., Fu, X., & Meadows, G. G. (2003) · Nutrition and Cancer · doi:10.1207/s15327914nc4501_8 · Cited by 51
Noh, E. J., Kang, S. W., Shin, Y. J., Kim, D. C., Park, I. S., Kim, M. Y., Chun, B. G., & Min, B.-H. (2002) · Molecules and Cells · doi:10.1016/s1016-8478(23)15015-1 · Cited by 50
Arginine deprivation therapy for malignant melanoma
Kim, K., Yoon, Y., Frankel, A. E., Feun, & Ekmekcioglu (2012) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s37350 · Cited by 50
Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia
Morrow, K. D., Hernandez, C. P., Raber, P. L., Valle, L. D., Wilk, A. M., Majumdar, S., Wyczechowska, D. D., Krzysztof Reiss, F., & Rodrı́guez, P. C. (2012) · Leukemia · doi:10.1038/leu.2012.247 · Cited by 50
Köhler, E., Sankaranarayanan, S., Ginneken, C. J. V., van Dijk, P., Vermeulen, J. L. M., Ruijter, J. M., Lamers, W. H., & Bruder, E. (2008) · BMC Developmental Biology · doi:10.1186/1471-213x-8-107 · Cited by 50
Synakiewicz, A., Stachowicz‐Stencel, T., & Adamkiewicz‐Drożyńska, E. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.934808 · Cited by 47
Autophagy regulates tissue overgrowth in a context-dependent manner
Pérez, E., Das, G., Bergmann, A., & Baehrecke, E. H. (2014) · Oncogene · doi:10.1038/onc.2014.285 · Cited by 46
Mayeur, C., Veuillet, G., Michaud, M., Raul, F., Blottière, H. M., & Blachier, F. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.12.004 · Cited by 45
Daylami, R., Muilenburg, D. J., Virudachalam, S., & Bold, R. J. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/preaccept-8245834981349245 · Cited by 42
Liu, J., Ma, J., Wu, Z., Li, W., Zhang, D., Han, L., Wang, F., Reindl, K. M., Wu, E., & Ma, Q. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-686 · Cited by 41
Arginine deprivation as a new treatment strategy for head and neck cancer
Huang, C., Tsai, S., Kuo, C., Chang, J. S.-M., Jin, Y., Chang, J., & Hsiao, J. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.06.004 · Cited by 41
Savaraj, N., Wu, C., Li, Y., Wangpaichitr, M., You, M., Bomalaski, J. S., He, W., Kuo, M. T., & Feun, L. G. (2015) · Oncotarget · doi:10.18632/oncotarget.3370 · Cited by 41
Noh, E., Kang, S., Shin, Y., Choi, S., Kim, C., Park, I.-S., Wheatley, D. N., & Min, B. (2004) · International Journal of Cancer · doi:10.1002/ijc.20435 · Cited by 40
Zhang, L., Liu, M., Jamil, S., Han, R., Xu, G., & Ni, Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.042 · Cited by 40
Recombinant arginine‐degrading enzymes in metabolic anticancer therapy and bioanalytics
Stasyk, O. V., Boretsky, Y. R., Gonchar, M. V., & Sibirny, A. А. (2014) · Cell Biology International · doi:10.1002/cbin.10383 · Cited by 39
THOMAS, J. B., Holtsberg, F. W., Ensor, M., Bomalaski, J. S., & Clark, M. A. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3630581 · Cited by 39
Control of the translational machinery by amino acids
Proud, C. G. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.066753 · Cited by 39
Takaku, H., Misawa, S., Hayashi, H., & Miyazaki, K. (1993) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1993.tb02821.x · Cited by 38
Endothelial Metabolism Driving Angiogenesis: Emerging Concepts and Principles
Cantelmo, A. R., Brajic, A., & Carmeliet, P. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000133 · Cited by 37
Crosstalk between oxygen- and nitric oxide-dependent signaling pathways in angiogenesis
Fraisl, P. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.02.010 · Cited by 37
Some aspects of the role of arginine and arginase in mouse carcinoma 63.
Sj, B., & Lasnitzki, I. (1947) · PubMed · Cited by 37
Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction
Cetinbas, N. M., Daugaard, M., Mullen, A. R., Hajee, S., Rotblat, B., Lopez, A., Li, A.-P., DeBerardinis, R. J., & Sørensen, P. (2014) · Oncogene · doi:10.1038/onc.2014.316 · Cited by 35
Bobak, Y. P., Vynnytska‐Myronovska, B., Kurlishchuk, Y. V., Sibirny, A. А., & Stasyk, O. V. (2010) · Cell Biology International · doi:10.1042/cbi20100451 · Cited by 34
The relationship of arginine deprivation, argininosuccinate synthetase and cell death in melanoma.
Savaraj, N., Wu, C., Kuo, M. T., You, M., Wangpaichitr, M., Robles, C., Spector, S. A., & Feun, L. G. (2007) · Europe PMC (PubMed Central) · Cited by 32
Anti-tumor Efficacy of a Recombinant Human Arginase in Human Hepatocellular Carcinoma
Chow, A. K.-M., Ng, L., Li, H. S., Cheng, C. W., Lam, C. S. C., Yau, T. C. C., Cheng, P., Fan, S. T., Poon, R. T. P., & Pang, R. W. C. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912803988002 · Cited by 32
Wang, Z., Shi, X., Li, Y., Zeng, X. L., Fan, J., Sun, Y., Xian, Z., Zhang, G., Wang, S., Hu, H., et al. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5118-0 · Cited by 31
Kim, J., Kim, S. C., Lee, K. W., & Lee, H. J. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509990432 · Cited by 31
Targeting methionine auxotrophy in cancer: discovery & exploration
Agrawal, V., Alpini, S. E., Stone, E. M., Frenkel, E. P., & Frankel, A. E. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.636349 · Cited by 30
The Relationship of Arginine Deprivation, Argininosuccinate Synthetase and Cell Death in Melanoma
Savaraj, N., Wu, C., Kuo, M. T., You, M., Wangpaichitr, M., Robles, C., Spector, S. A., & Feun, L. G. (2007) · Drug Target Insights · doi:10.1177/117739280700200016 · Cited by 30
The combination of ADI-PEG20 and TRAIL effectively increases cell death in melanoma cell lines
You, M., Savaraj, N., Wangpaichitr, M., Wu, C., Kuo, M. T., Varona-Santos, J., Nguyen, D. M., & Feun, L. G. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.066 · Cited by 29
Amino acid sensing and regulation of mTORC1
Yan, L., & Lamb, R. F. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.02.001 · Cited by 28
Luo, J., Chen, D., & Yu, B. (2012) · Nutrition · doi:10.1016/j.nut.2012.05.008 · Cited by 28
Anti-tumor activity of arginine deiminase via arginine deprivation in retinoblastoma
Kim, J. H., Kim, J. H., Yu, Y. S., Kim, D. W., Min, B.-H., & Kim, K.-W. (2007) · Oncology Reports · doi:10.3892/or.18.6.1373 · Cited by 26
Gill, P. G., & Pan, J. (1970) · Canadian Journal of Microbiology · doi:10.1139/m70-071 · Cited by 25
Ohmura, M., Hishiki, T., Yamamoto, T., Nakanishi, T., Kubo, A., Tsuchihashi, K., Tamada, M., Toue, S., Kabe, Y., Saya, H., et al. (2014) · Nitric Oxide · doi:10.1016/j.niox.2014.11.005 · Cited by 25
Gelb, T., Pshenichkin, S. P., Rodriguez, O. C., Hathaway, H. A., Grajkowska, E., DiRaddo, J. O., Wróblewska, B., Yasuda, R. P., Albanese, C., Wolfe, B. B., et al. (2014) · Oncogene · doi:10.1038/onc.2014.231 · Cited by 25
Palmieri, G. (2011) · Oncology Reports · doi:10.3892/or.2011.1220 · Cited by 25
An Engineered Arginase FC Protein Inhibits Tumor GrowthIn VitroandIn Vivo
Li, L., Wang, Y., Chen, J., Cheng, B., Hu, J., Zhou, Y., Gao, X., Gao, L., Mei, X., Sun, M., et al. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/423129 · Cited by 24
Combination of arginine deprivation with TRAIL treatment as a targeted-therapy for mesothelioma.
Wangpaichitr, M., Wu, C., Bigford, G. E., Theodoropoulos, G. E., You, M., Li, Y. Y., Varona-Santos, J., Feun, L. G., Nguyen, D. M., & Savaraj, N. (2014) · PubMed · Cited by 17
Feun, L. G., Wu, C., Clark, M. E., Bombalaski, J., Holtsberg, F. W., Wangpaijit, M., Robles, C., & Savaraj, N. (2004) · Cancer Research · Cited by 16
Cited by
mTOR signalling and cellular metabolism are mutual determinants in cancer
Mossmann, D., Park, S., & Hall, M. N. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0074-8 · Cited by 1,088
Metabolic programming and immune suppression in the tumor microenvironment
Arner, E. N., & Rathmell, J. C. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.01.009 · Cited by 668
Grams, R. J., Santos, W. L., Scorei, I. R., Abad-García, A., Rosenblum, C. A., Bita, A., Cerecetto, H., Viñas, C., & Soriano-Ursúa, M. A. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00663 · Cited by 377
Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors
Andrejeva, G., & Rathmell, J. C. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.004 · Cited by 373
Autophagy maintains tumour growth through circulating arginine
Poillet-Perez, L., Xie, X., Zhan, L., Yang, Y., Sharp, D. W., Hu, Z. S., Su, X., Maganti, A., Jiang, C., Lu, W., et al. (2018) · Nature · doi:10.1038/s41586-018-0697-7 · Cited by 360
Metadata
- Authors
- Patil, M. D., Bhaumik, J., Babykutty, S., Banerjee, U. C., & Fukumura, D.
- Venue
- Oncogene
- Published
- 2016-04-25
- Volume
- 35
- Issue
- 38
- Pages
- 4957-4972
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2342912708
- Cited by
- 265
- References
- 203
- FWCI
- 16.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.